Clinical Trials Directory

Trials / Recruiting

RecruitingNCT04862507

Improving Low ASPECTS Stroke Thrombectomy

Improving Low Alberta Stroke Program Early ct Score Stroke Thrombectomy

Status
Recruiting
Phase
Study type
Observational
Enrollment
500 (estimated)
Sponsor
Universitätsklinikum Hamburg-Eppendorf · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

Improving Low ASPECTS Stroke Thromectomy (I-LAST) is an academic, independent, prospective, multicenter, observational registry study. Consecutive patients treated with endovascular stroke treatment will be enrolled in German stroke centers. Patients receive regular care and data will be collected as part of clinical routine. Baseline clinical and procedural information as well clinical follow-up information during in-hospital stay, and up to 90 days of stroke onset are collected. Data collected include demographics, National Institute of Health Stroke Scale (NIHSS) on admission, pre-treatment ASPECTS, information on timing and success of interventional treatment, procedural complications, intracranial hemorrhage, and functional outcome. Advanced imaging biomarkers will be tested and validated aiming to improve treatment selection and outcome prediction of patients presenting with extensive baseline infarction.

Detailed description

This study aims to investigate the role of advanced imaging biomarkers in patients with large early infarct, in particular quantitative lesion water uptake (Minnerup et al. Annals of Neurology 2016), arterial and venous collateral circulation (Faizy et al. Radiology 2021), and multivariate CTP-derived parameters (Kemmling et al. JCBFM 2015). The goal is to use these imaging biomarkers as specific selection criterion to predict clinical benefit after reperfusion despite extensive baseline infarct lesions, also as a method of monitoring adjuvant neuroprotective agents after reperfusion therapy (for instance anti-edematous medication).

Conditions

Interventions

TypeNameDescription
OTHERTelephone call on day 90telephone call on day 90 to assess the primary outcome (mRs 90)
DIAGNOSTIC_TESTQuantification of lesion water uptake by CT densitometryRetrospective quantification of lesion water uptake by CT densitometry in admission and follow-up imaging

Timeline

Start date
2023-05-01
Primary completion
2027-01-01
Completion
2028-01-01
First posted
2021-04-28
Last updated
2023-05-24

Locations

8 sites across 2 countries: Germany, Switzerland

Source: ClinicalTrials.gov record NCT04862507. Inclusion in this directory is not an endorsement.